Royal Bank of Canada’s Eton Pharmaceutcials ETON Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $72K | Buy |
5,065
+3,436
| +211% | +$48.8K | ﹤0.01% | 5404 |
|
|
2025
Q1 | $22K | Buy |
1,629
+877
| +117% | +$11.8K | ﹤0.01% | 5494 |
|
|
2024
Q4 | $10K | Buy |
752
+477
| +173% | +$6.34K | ﹤0.01% | 5849 |
|
|
2024
Q3 | $2K | Sell |
275
-472
| -63% | -$3.43K | ﹤0.01% | 6165 |
|
|
2024
Q2 | $2K | Sell |
747
-18
| -2% | -$48 | ﹤0.01% | 6326 |
|
|
2024
Q1 | $3K | Sell |
765
-1,866
| -71% | -$7.32K | ﹤0.01% | 6137 |
|
|
2023
Q4 | $12K | Buy |
+2,631
| New | +$12K | ﹤0.01% | 5907 |
|
|
2023
Q3 | – | Sell |
-4,881
| Closed | -$17K | – | 6671 |
|
|
2023
Q2 | $17K | Buy |
4,881
+4,511
| +1,219% | +$15.7K | ﹤0.01% | 5823 |
|
|
2023
Q1 | $1K | Buy |
+370
| New | +$1K | ﹤0.01% | 6491 |
|
|
2022
Q4 | – | Sell |
-49
| Closed | – | – | 6843 |
|
|
2022
Q3 | $0 | Buy |
+49
| New | – | ﹤0.01% | 7027 |
|
|
2022
Q2 | – | Sell |
-23
| Closed | – | – | 6953 |
|
|
2022
Q1 | $0 | Buy |
+23
| New | – | ﹤0.01% | 7279 |
|
|
2021
Q4 | – | Sell |
-1,000
| Closed | -$5K | – | 7143 |
|
|
2021
Q3 | $5K | Sell |
1,000
-2,113
| -68% | -$10.6K | ﹤0.01% | 6601 |
|
|
2021
Q2 | $19K | Sell |
3,113
-57,308
| -95% | -$350K | ﹤0.01% | 6082 |
|
|
2021
Q1 | $443K | Buy |
60,421
+334
| +0.6% | +$2.45K | ﹤0.01% | 3841 |
|
|
2020
Q4 | $488K | Buy |
60,087
+828
| +1% | +$6.73K | ﹤0.01% | 3665 |
|
|
2020
Q3 | $469K | Sell |
59,259
-988
| -2% | -$7.82K | ﹤0.01% | 3473 |
|
|
2020
Q2 | $328K | Sell |
60,247
-5,002
| -8% | -$27.2K | ﹤0.01% | 3664 |
|
|
2020
Q1 | $268K | Buy |
65,249
+1,032
| +2% | +$4.24K | ﹤0.01% | 3660 |
|
|
2019
Q4 | $462K | Buy |
64,217
+63,111
| +5,706% | +$454K | ﹤0.01% | 3485 |
|
|
2019
Q3 | $7K | Buy |
+1,106
| New | +$7K | ﹤0.01% | 5257 |
|